Categories
- Aesthetic Medicine
- Aesthetic Surgery
- Ai
- ALS Treatment
- Anatomy
- Artificial General Intelligence
- Artificial Intelligence
- Artificial Super Intelligence
- Batten Disease Treatment
- BioEngineering
- BioInformatics
- Biology
- Biotechnology
- Bitcoin
- Brain Injury Treatment
- Cardiac Nursing
- Cardiac Regeneration
- Cardiac Remodeling
- Cardiac Rhythm Abnormalities
- Cardiac Surgery
- Cardiology
- Cardiomyopathies
- Cardiovascular Pharmacology
- Cell Medicine
- Cell Therapy
- Cerebral Palsy
- Cerebral Palsy Treatment
- Cheap Pharmacy
- Chemistry
- Clinical Cardiology
- Coronary Heart Diseases
- Cryptocurrency
- DNA
- Drug Dependency
- Drug Side Effects
- Drugs
- Eczema
- Elon Musk
- Embryology
- Erectile Dysfunction
- FDA Stem Cell Trials
- Femtomedicine
- Future Medicine
- Gene Medicine
- Gene Therapy
- Gene Therapy Trials
- Genetic Engineering
- Genetic Therapy
- Genetics
- Germ Line Engineering
- Heart Diseases
- HGH
- Hgh Injections
- Hormone Replacement Therapy
- Human Genetics
- Human Growth Hormone
- Human Immortality
- Hyperbaric Medicine
- Hypertension
- Hypothalamus
- Impotency
- Internet Pharmacy
- Interventional Cardiology
- IVF Treatment
- Lyme Disease
- Male Sexual Dysfunction
- Mars Colony
- Medical Business
- Medical School
- Medical Technology
- Medicine
- Mental Health
- Mesenchymal Stem Cells
- Micropenia
- Molecular Cardiology
- MS Treatment
- Muscular Dystrophy Treatment
- Myocardial Infarction
- Nanotechnology
- Online Pharmacy
- Oral Health
- Parkinson's Treatment
- Pediatric Cardiology
- Penis Enlargement
- Pet Stem Cell Therapy
- Pharmacy
- Picomedicine
- Premature Ejaculation
- Prescriptions
- Retinitis Pigmentosa
- Sermorelin
- Singularity
- Sleep
- Spacex
- Spinal Cord Injury Treatment
- Stem Cell Clinical Trials
- Stem Cell Experiments
- Stem Cell Human Trials
- Stem Cell Injections
- Stem Cell Research
- Stem Cell Transplant
- Stem Cell Treatments
- Testosterone
- Ulcerative Colitis
- Uncategorized
- Vascular Biology
- Ventricular Remodeling
- Wholesale Pharmacy
Archives
Monthly Archives: February 2012
BioTime CEO Michael D. West to Present at New York Stem Cell Summit
Posted: Published on February 18th, 2012
ALAMEDA, Calif.--(BUSINESS WIRE)-- BioTime, Inc. (NYSE Amex: BTX), a biotechnology company that develops and markets products in the field of regenerative medicine, today announced that Chief Executive Officer Michael D. West, Ph.D. will present at the 7th Annual New York Stem Cell Summit at Bridgewaters New York City on Tuesday, February 21, 2012 at 8:48 a.m. ET. Dr. West will provide an update and new information on the Company's manufacturing technologies and cell-based therapeutics in development. The presentation will be available online at http://www.biotimeinc.com. The annual New York Stem Cell Summit provides investors, industry, practitioners, and analysts with the latest developments and investment opportunities in the stem cell marketplace. About BioTime, Inc. BioTime, headquartered in Alameda, California, is a biotechnology company focused on regenerative medicine and blood plasma volume expanders. Its broad platform of stem cell technologies is developed through subsidiaries focused on specific fields of applications. BioTime develops and markets research products in the field of stem cells and regenerative medicine, including a wide array of proprietary ACTCellerate™ cell lines, culture media, and differentiation kits. BioTime's wholly owned subsidiary ES Cell International Pte. Ltd. has produced clinical-grade human embryonic stem cell lines that were derived following principles of Good … Continue reading
Comments Off on BioTime CEO Michael D. West to Present at New York Stem Cell Summit
Brain differences found at 6 months in infants who develop autism
Posted: Published on February 18th, 2012
ScienceDaily (Feb. 17, 2012) — A new study from the Infant Brain Imaging Network, which includes researchers at the Center for Autism Research at The Children's Hospital of Philadelphia (CHOP), found significant differences in brain development starting at age 6 months in high-risk infants who later develop autism, compared to high-risk infants who did not develop autism. "It's a tremendously exciting finding," said Sarah Paterson, PhD, director of the Infant Neuroimaging Lab at CHOP's Center for Autism Research. "We found that the brains of the children who developed autism were markedly different even prior to the onset of behavioral symptoms of autism. Thus, our findings, while requiring replication, are a very important first step towards identifying a biomarker for autism risk. This would enable specialists to diagnose autism much earlier than what is currently possible through behavioral observations." The study also suggests that autism does not appear suddenly in young children but instead develops over time during infancy, note the authors. Intensive early intervention has been shown to improve outcomes in children with developmental delays and autism. "This research raises the possibility that we might be able to intervene even before a child is 6 months old, to blunt or … Continue reading
Comments Off on Brain differences found at 6 months in infants who develop autism
Autism Detection as Early as 6 Months Old, Study Finds
Posted: Published on February 18th, 2012
The brains of children with autism start to differ from typical children as early as 6 months old, a new study found. The earlier timeframe could lead to therapies for autistic children during critical developmental stages, researchers suggested. On average, physicians diagnose infants at 18 months for autism, a disorder known for its symptoms of poor social skills, delay in learning to talk and limited interests in activities, according to the Mayo Clinic. "It's a promising finding," Jason Wolff, lead study author and postdoctoral fellow at the University of North Carolina, told EurekAlert. "At this point, it's a preliminary, albeit great, first step towards thinking about developing a [benchmark] for risk in advance of our current ability to diagnose autism." Like us on Facebook Researchers examined 92 at-risk infants who had autistic siblings. Autism affects one in 110 children in the United States, and researchers suspect the disorder has a genetic component since families with an autistic child have a one in five chance of having another, according to the Centers for Disease Control and Prevention. Researchers studied how different parts of the brains communicate with each other in infants aged 6, 12 and 24 months of age using magnetic … Continue reading
Comments Off on Autism Detection as Early as 6 Months Old, Study Finds
Redefining Autism: Proposal Worries Many Parents
Posted: Published on February 18th, 2012
When Caleb Geary was diagnosed with autism at age 3, he had never spoken or eaten solid food. Now 6, the boy speaks and tests at his first-grade level — progress that his parents attribute to insurance-based services at home and intensive behavioral intervention at the boy's school in Hamden. But they worry what will happen to Caleb's diagnosis — and the services that have come with it — if the American Psychiatry Association's proposal to change the definition of autism is adopted. Lori Geary said she has already fought to get her son the help he needs. Tom Zwicker, Caleb's father and the director of an autism center for the Easter Seals of Coastal Fairfield County, said he believes insurance companies will start requesting annual diagnostic evaluations if the definition is revised. As a result, his son — and many other children — will lose out on services to treat their conditions. "You have an entire group receiving services that would be left out in the cold," said Zwicker, who lives in Branford. "We're going to lose a whole generation of children." The autism community has been embroiled in a heated debate for the past few weeks over the … Continue reading
Comments Off on Redefining Autism: Proposal Worries Many Parents
Autism signs detected in brain scans of infants
Posted: Published on February 18th, 2012
(CBS) Brain scans of infants may predict high risk for autism, new research shows. While symptoms of an autism spectrum disorder usually appear before age three, they are typically not identified until after a child's first birthday. PICTURES - Autism-spectrum disorders: 24 warning signs The new study - published in the Feb. 17 edition of the American Journal of Psychiatry - looked at the brain development of 92 high-risk infants ages 6 to 24 months. The babies were considered high-risk because they all have older brothers or sisters who have been diagnosed with an autism spectrum disorder, said the researchers from the Infant Brain Imaging Study network. The infants underwent a type of MRI called diffusion tensor imaging at 6 months, 1 year and 2 years of age. With the repeated scans, researchers created 3D pictures that showed changes in white matter - the part of the brain embedded with nerve fibers that help different areas of the brain connect with one another. What did they find? Researchers saw differences in the brain matter of children who were eventually diagnosed with an autism spectrum disorder by age 2. These children were more likely to show thicker, denser nerve-fiber readings at … Continue reading
Comments Off on Autism signs detected in brain scans of infants
Brain Scans Might Spot Autism as Early as 6 Months of Age
Posted: Published on February 18th, 2012
FRIDAY, Feb. 17 (HealthDay News) -- In children as young as 6 months old, changes in the brain that can lead to autism spectrum disorder may have already begun, preliminary research suggests. Although early signs of autism, such as problems communicating and repetitive behaviors, can often be seen as early as 1 year, processes in the brain linked to communication are seemingly being altered months earlier, University of North Carolina researchers report. "We know that there is evidence that autism affects the ability of different brain regions to communicate with each other. This study confirms that this atypical brain development begins very early in life," said study co-author Geri Dawson, the chief science officer at Autism Speaks. "These findings raise the possibility of developing imaging markers that could detect risk for autism in advance of actual symptoms, and [to] begin treatment before symptoms begin," she said. However, whether these brain changes occur in all autistic children isn't known, Dawson said. It is possible that the developmental problems of autism start even earlier, while in the womb, she said. "One can imagine a day when you would use these imaging biomarkers to identify a young baby who is at risk and … Continue reading
Comments Off on Brain Scans Might Spot Autism as Early as 6 Months of Age
Henry Mayo receives stroke care awareness award
Posted: Published on February 18th, 2012
Henry Mayo Newhall Memorial Hospital has received a stroke care awareness award after the hospital implemented a higher standard of stroke care. The American Heart Association/ American Stroke Association's Get With The Guidelines - Stroke Silver Plus Quality Achievement Award is given to hospitals that ensure stroke patients receive treatment according to nationally accepted standards and recommendations, according to a statement from Henry Mayo. The Santa Clarita Valley's only hospital has developed a comprehensive system for rapid diagnosis and treatment of stroke patients admitted to the Emergency Department, it said in a news release. The program means the hospital will always be equipped to provide brain imaging scans, have neurologists available to conduct patient evaluations and use clot-busting medications when appropriate. The program uses the time soon after a patient has had a stroke when he or she is most likely to listen to and follow doctor's guidance. Studies show patients who are taught how to manage their risk factors while still in the hospital reduce their risk of a second heart attack or stroke. More: Henry Mayo receives stroke care awareness award … Continue reading
Comments Off on Henry Mayo receives stroke care awareness award
Dash to help – new app to improve stroke treatment
Posted: Published on February 18th, 2012
Having developed the FAST acronym – face, arms, speech and time – which has been seen on TV ads, the University and NHS team are now trying out an app to help people who have had a stroke and their medical team work out which course of treatment is most suitable for them. Its potential benefits have caught the attention of the national NHS after the team were nominated by a public vote as one of the top 50 uses of technology. The app will be demonstrated to the Secretary of State for Health, Andrew Lansley, at the Maps and Apps Showcase in London (on Weds 22nd Feb). From the moment people suffer a stroke medics only have a four and a half hour window to treat them with clot busting drugs – and this means doctors, nurses, the patient and their families need to have a clear idea of the treatment options so they can make a considered but rapid decision. An iPad app, called DASH II, is being trialled in Newcastle and North Tyneside hospitals to help weigh up the risks and benefits of different treatments for people who have had an ischaemic stroke, caused by a blood … Continue reading
Comments Off on Dash to help – new app to improve stroke treatment
Research and Markets: Hormone Replacement Therapy (HRT) – Global Strategic Business Report
Posted: Published on February 18th, 2012
DUBLIN--(BUSINESS WIRE)-- Research and Markets (http://www.researchandmarkets.com/research/2dd8e6/hormone_replacemen) has announced the addition of the "Hormone Replacement Therapy (HRT) - Global Strategic Business Report" report to their offering. This report analyzes the worldwide markets for Hormone Replacement Therapy (HRT) in US$ Million. The report provides separate comprehensive analytics for the US, Canada, Europe, Asia-Pacific, and Rest of World. Annual estimates and forecasts are provided for the period 2009 through 2017. A six-year historic analysis is also provided for these markets. The Report Profiles 42 Companies Including Many Key and Niche Players Such As: Bayer HealthCare Pharmaceuticals, Inc. Besins Healthcare SA Hisamitsu Pharmaceutical Co. Inc. Noven Pharmaceuticals Inc. Mylan Canada Novartis AG Novo Nordisk A/S Orion Corporation Pfizer Inc. Wyeth Pharmaceuticals Inc. Rottapharm SpA Teva Pharmaceutical Industries Ltd. Thramex Warner Chilcott Watson Pharmaceuticals Inc. Market data and analytics are derived from primary and secondary research. Company profiles are mostly extracted from URL research and reported select online sources. Key Topics Covered: 1. INTRODUCTION, METHODOLOGY & PRODUCT DEFINITIONS 2. INDUSTRY OVERVIEW 3. MARKET TRENDS 4. PRODUCT OVERVIEW 5. RECENT INDUSTRY ACTIVITY 6. FOCUS ON SELECT KEY PLAYERS 7. GLOBAL MARKET PERSPECTIVE 8. THE UNITED STATES 9. CANADA 10. EUROPE 11. ASIA-PACIFIC 12. REST OF WORLD … Continue reading
Posted in Hormone Replacement Therapy
Comments Off on Research and Markets: Hormone Replacement Therapy (HRT) – Global Strategic Business Report
Blood Cancer Patients To Benefit From Stem Cell Research Breakthrough
Posted: Published on February 18th, 2012
Editor's Choice Academic Journal Main Category: Lymphoma / Leukemia / Myeloma Also Included In: Blood / Hematology; Cancer / Oncology; Stem Cell Research Article Date: 17 Feb 2012 - 9:00 PST email to a friend printer friendly opinions Current Article Ratings: Patient / Public: Healthcare Prof: 3 (1 votes) A landmark study published Online First in The Lancet Oncology , describes the discovery of a unique matching mechanism that affects the outcome of blood stem cell transplants and helps improving survival rates for sufferers from leukemia and other blood cancers. Often, the last glimmer of hope for blood cancer sufferers who remain unresponsive to all other treatment options is to receive blood stem cells, also called haemopoietic cells, from an unrelated, living donor. An allele is an alternative form of a gene, i.e. one member of a pair that is located at a specific position on a specific chromosome. Doctors look for matches of the human leukocyte antigen (HLA) type of five key alleles that occur in a blood stem cell to achieve a 10/10 match to reduce the risks linked to transplants, such as acute Graft versus Host Disease (aGvHD). However, due to complex reasons that are not … Continue reading
Posted in Stem Cell Research
Comments Off on Blood Cancer Patients To Benefit From Stem Cell Research Breakthrough